Clinical Trial Update: Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for CKD-215 and D215 in BRCA-mutated advanced ovarian, fallopian tube, or primary peritoneal cancer; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CKD-215
• D215

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Ovarian Cancer | Phase 1 | Status: NOT_YET_RECRUITING